Johnson & Johnson on Wednesday disclosed two more cases of people who suffered from rare blood clots after receiving the company’s COVID-19 vaccine — including an otherwise healthy, 25-year-old man.
They are in addition to the six previously reported women who suffered from clotting — prompting federal health officials to pause use of the vaccine Tuesday.
The man received the shot during a clinical trial for the vaccine on Sept. 21, a company rep said during an emergency Centers for Disease Control and Prevention advisory meeting.
Eight days after getting the single-dose jab, the man began suffering from “fatigue, faintness, and headache” followed by abdominal pain — and was hospitalized with a cerebral hemorrhage, the company rep said.
He underwent repeated procedures,